Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Zynerba PharmaceuticalsImmune DesignPhaseBio PharmaceuticalsOptiNoseTapImmune
SymbolNASDAQ:ZYNENASDAQ:IMDZNASDAQ:PHASNASDAQ:OPTNNASDAQ:MRKR
Price Information
Current Price$13.94$5.85$10.75$7.36$8.94
52 Week RangeBuyHoldBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$25.00$7.00$19.6667$27.25$10.9020
% Upside from Price Target79.34% upside19.66% upside82.95% upside270.24% upside21.95% upside
Trade Information
Market Cap$293.79 million$282.96 million$274.87 million$318.12 million$399.81 million
Beta4.883.48N/A0.930.33
Average Volume1,913,782374,216300,284170,716427,925
Sales & Book Value
Annual Revenue$90,000.00$2.20 million$670,000.00$7.07 million$210,000.00
Price / Sales3,264.28128.62393.0642.961,936.32
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$3.27 per share$1.91 per share$2.08 per share$2.88 per share$1.31 per share
Price / Book4.263.065.172.566.82
Profitability
Net Income$-39,910,000.00$-54,760,000.00$-23,850,000.00$-106,660,000.00$-147,960,000.00
EPS($2.61)($1.75)($4.49)($2.68)($1.67)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-2,483.00%N/A-983.22%N/A
Return on Equity (ROE)-64.06%-49.56%N/A-81.04%-113.66%
Return on Assets (ROA)-54.86%-46.21%N/A-46.26%-102.04%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.19%0.79%0.01%
Current Ratio9.94%11.33%14.24%6.95%19.73%
Quick Ratio9.94%11.32%14.24%6.74%19.73%
Ownership Information
Institutional Ownership Percentage10.94%61.72%28.27%63.68%33.64%
Insider Ownership Percentage10.79%18.10%17.00%44.30%23.70%
Miscellaneous
Employees25482210211
Shares Outstanding21.08 million48.37 million24.50 million41.26 million45.48 million
Next Earnings Date8/1/2019 (Estimated)N/A8/8/2019 (Estimated)8/13/2019 (Estimated)8/8/2019 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableOptionable
 Zynerba PharmaceuticalsImmune DesignPhaseBio PharmaceuticalsOptiNoseTapImmune

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel